SEC Form D raise Raised $40.73M (Form D filed Apr 22, 2026); 1 role open. SEC Form D 0001231919-26-000386 (Apr 22, 2026)Evidence (1 event)
Apr 22, 2026 · SEC Form D 0001231919-26-000386 Name of Issuer: Terremoto Biosciences, Inc.; CIK: 2130748; Address: South San Francisco, CA; Submission type: D; Filing date: 2026-04-22; Industry Group: Biotechnology; Date of First Sale: 2026-04-10; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 108599999; Total Amount Sold: 40725000; Federal exemptions: 06b
Raise Series C · $108M · announced Apr 15, 2026 Company release ↗Source quote
Apr 15, 2026 · Company release ↗ “– Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, today announced the closing of a $108 million Series C financing round”
Raise Series B · $175M · announced Nov 2, 2023 Company release ↗Source quote
Nov 2, 2023 · Company release ↗ “– Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, today announced the closing of a $175 million Series B financing round”
Raise Series B · $175M · announced Oct 31, 2023 Company release ↗Source quote
Oct 31, 2023 · Company release ↗ “Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, today announced the closing of a $175 million Series B financing round”
Nov 2, 2023 · Company release ↗ “– Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, today announced the closing of a $175 million Series B financing round”
Raises announced in these releases: $458M disclosed.
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
